Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 1;56(7):1069-1080.
doi: 10.1093/rheumatology/kew307.

Kidney disease in primary anti-phospholipid antibody syndrome

Affiliations
Review

Kidney disease in primary anti-phospholipid antibody syndrome

Borja Gracia-Tello et al. Rheumatology (Oxford). .

Abstract

APS is an autoimmune disease defined by the presence of arterial or venous thrombotic events and/or pregnancy morbidity in patients who test positive for aPL. APS can be isolated (primary APS) or associated with other autoimmune diseases. The kidney is a major target organ in APS, and renal thrombosis can occur at any level within the vasculature of the kidney (renal arteries, intrarenal vasculature and renal veins). Histological findings vary widely, including ischaemic glomeruli and thrombotic lesions without glomerular or arterial immune deposits on immunofluorescence. Renal involvement in patients with definite APS is treated with long-term anticoagulants as warfarin, but new treatments are being tried. The aim of this article is to review the links between primary APS and kidney disease.

Keywords: anti-phospholipid antibodies; anti-phospholipid–associated nephropathy; kidney disease; primary anti-phospholipid syndrome; thrombosis; treatment.

PubMed Disclaimer

Comment in

MeSH terms

Substances